Company intelligence / Profile preview
Mepha
Basel, Basel, Switzerlandpmc.ncbi.nlm.nih.gov ↗
- Ownership
- Private
- Employees
- ~170
- Development stage
- Commercial
01
Overview
Leading Swiss generic pharmaceutical company with over one-third market share in Switzerland. Offers more than 230 branded and non-branded preparations covering a wide range of therapeutic areas. Known for high-quality standards and innovative drug delivery approaches. Active in malaria research. Now operates as part of Teva Pharmaceutical Industries.[1][2][5][6]
- Therapeutic areas
- CardiovascularImmunologyOtherOncologyInfectious Diseases
- Modalities
- small molecules (branded and non-branded generics)improved branded generics using new formulations or drug delivery technologies[5]
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
Partnerships to distribute products across Europe, Middle East, Africa, South & Central America [5]; now leverages Teva’s global partnerships
Beyond the preview
Go deeper on Mepha.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Mepha.